Table 1 Clinical characteristics of the participants
Characteristics | Total (n = 63) |
|---|---|
Vascular risk factors | |
Age (years) | 57.0 (48.0, 64.0) |
Sex (male), % | 55 (87.3) |
Hypertension, % | 45 (71.4) |
Diabetes mellitus, % | 14 (22.2) |
Current smoking, % | 31 (49.2) |
BMI | 24.2 (22.2, 26.0) |
Total cholesterol (mmol/L) | 1.4 (1.1, 1.8) |
Triglycerides (mmol/L) | 3.9 (3.1, 4.8) |
Homocysteine (μmol/L) | 12.1 (9.7, 14.5) |
MAP on admission (mmHg) | 106.3 (101.0, 119.0) |
MAP > 105 mmHg on admission, % | 35 (55.6) |
Brain MRI Markers | |
Lacunae, % | 37 (58.7) |
Microbleeds, % | 20 (31.7) |
Perivascular space, % | 13 (20.6) |
White matter hyperintensities, % | 13 (20.6) |
Total CSVD burden score (0/1/2/3/4), % | 14/30/7/9/3 (22.2/47.6/11.1/14.3/4.8) |
CA parameters | |
Ipsilateral gain, (%/%) | 0.6 (0.4, 0.8) |
Contralateral gain, (%/%) | 0.5 (0.4, 0.7) |
Ipsilateral phase, degree | 25.8 (13.5, 34.6) |
Contralateral phase, degree | 25.7 (15.9, 34.7) |